Literature DB >> 32707077

Emergence of a High-Plasticity Cell State during Lung Cancer Evolution.

Nemanja Despot Marjanovic1, Matan Hofree2, Jason E Chan3, David Canner4, Katherine Wu5, Marianna Trakala4, Griffin G Hartmann5, Olivia C Smith6, Jonathan Y Kim6, Kelly Victoria Evans7, Anna Hudson5, Orr Ashenberg2, Caroline B M Porter2, Alborz Bejnood2, Ayshwarya Subramanian2, Kenneth Pitter8, Yan Yan5, Toni Delorey2, Devan R Phillips2, Nisargbhai Shah9, Ojasvi Chaudhary10, Alexander Tsankov11, Travis Hollmann12, Natasha Rekhtman12, Pierre P Massion13, John T Poirier14, Linas Mazutis10, Ruifang Li15, Joo-Hyeon Lee7, Angelika Amon16, Charles M Rudin17, Tyler Jacks18, Aviv Regev19, Tuomas Tammela20.   

Abstract

Tumor evolution from a single cell into a malignant, heterogeneous tissue remains poorly understood. Here, we profile single-cell transcriptomes of genetically engineered mouse lung tumors at seven stages, from pre-neoplastic hyperplasia to adenocarcinoma. The diversity of transcriptional states increases over time and is reproducible across tumors and mice. Cancer cells progressively adopt alternate lineage identities, computationally predicted to be mediated through a common transitional, high-plasticity cell state (HPCS). Accordingly, HPCS cells prospectively isolated from mouse tumors and human patient-derived xenografts display high capacity for differentiation and proliferation. The HPCS program is associated with poor survival across human cancers and demonstrates chemoresistance in mice. Our study reveals a central principle underpinning intra-tumoral heterogeneity and motivates therapeutic targeting of the HPCS.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cell state transition; chromatin state; differentiation; drug resistance; lung cancer; plasticity; single-cell transcriptomics; tumor evolution; tumor heterogeneity; tumor progression

Mesh:

Year:  2020        PMID: 32707077      PMCID: PMC7745838          DOI: 10.1016/j.ccell.2020.06.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  92 in total

1.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

2.  The differential effects of mutant p53 alleles on advanced murine lung cancer.

Authors:  Erica L Jackson; Kenneth P Olive; David A Tuveson; Roderick Bronson; Denise Crowley; Michael Brown; Tyler Jacks
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

3.  The emergent landscape of the mouse gut endoderm at single-cell resolution.

Authors:  Sonja Nowotschin; Manu Setty; Ying-Yi Kuo; Vincent Liu; Vidur Garg; Roshan Sharma; Claire S Simon; Nestor Saiz; Rui Gardner; Stéphane C Boutet; Deanna M Church; Pamela A Hoodless; Anna-Katerina Hadjantonakis; Dana Pe'er
Journal:  Nature       Date:  2019-04-08       Impact factor: 49.962

4.  Stage-specific sensitivity to p53 restoration during lung cancer progression.

Authors:  David M Feldser; Kamena K Kostova; Monte M Winslow; Sarah E Taylor; Chris Cashman; Charles A Whittaker; Francisco J Sanchez-Rivera; Rebecca Resnick; Roderick Bronson; Michael T Hemann; Tyler Jacks
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

5.  Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection.

Authors:  Dmitry Yarilin; Ke Xu; Mesruh Turkekul; Ning Fan; Yevgeniy Romin; Sho Fijisawa; Afsar Barlas; Katia Manova-Todorova
Journal:  Sci Rep       Date:  2015-03-31       Impact factor: 4.379

6.  Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous.

Authors:  Wei-Jen Chung; Anneleen Daemen; Jason H Cheng; Jason E Long; Jonathan E Cooper; Bu-Er Wang; Christopher Tran; Mallika Singh; Florian Gnad; Zora Modrusan; Oded Foreman; Melissa R Junttila
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

7.  EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data.

Authors:  Aaron T L Lun; Samantha Riesenfeld; Tallulah Andrews; The Phuong Dao; Tomas Gomes; John C Marioni
Journal:  Genome Biol       Date:  2019-03-22       Impact factor: 13.583

8.  Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq.

Authors:  Dylan Kotliar; Adrian Veres; M Aurel Nagy; Shervin Tabrizi; Eran Hodis; Douglas A Melton; Pardis C Sabeti
Journal:  Elife       Date:  2019-07-08       Impact factor: 8.140

9.  miR-17-92/p38α Dysregulation Enhances Wnt Signaling and Selects Lgr6+ Cancer Stem-like Cells during Lung Adenocarcinoma Progression.

Authors:  Anna Guinot; Feride Oeztuerk-Winder; Juan-Jose Ventura
Journal:  Cancer Res       Date:  2016-05-04       Impact factor: 12.701

10.  Induction and transcriptional regulation of the co-inhibitory gene module in T cells.

Authors:  Norio Chihara; Asaf Madi; Takaaki Kondo; Huiyuan Zhang; Nandini Acharya; Meromit Singer; Jackson Nyman; Nemanja D Marjanovic; Monika S Kowalczyk; Chao Wang; Sema Kurtulus; Travis Law; Yasaman Etminan; James Nevin; Christopher D Buckley; Patrick R Burkett; Jason D Buenrostro; Orit Rozenblatt-Rosen; Ana C Anderson; Aviv Regev; Vijay K Kuchroo
Journal:  Nature       Date:  2018-06-13       Impact factor: 49.962

View more
  63 in total

Review 1.  Genetic and non-genetic clonal diversity in cancer evolution.

Authors:  James R M Black; Nicholas McGranahan
Journal:  Nat Rev Cancer       Date:  2021-03-16       Impact factor: 60.716

2.  Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer.

Authors:  Alexandre F Aissa; Abul B M M K Islam; Majd M Ariss; Cammille C Go; Alexandra E Rader; Ryan D Conrardy; Alexa M Gajda; Carlota Rubio-Perez; Klara Valyi-Nagy; Mary Pasquinelli; Lawrence E Feldman; Stefan J Green; Nuria Lopez-Bigas; Maxim V Frolov; Elizaveta V Benevolenskaya
Journal:  Nat Commun       Date:  2021-03-12       Impact factor: 14.919

3.  Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.

Authors:  Shaolong Cao; Jennifer R Wang; Shuangxi Ji; Peng Yang; Yaoyi Dai; Shuai Guo; Matthew D Montierth; John Paul Shen; Xiao Zhao; Jingxiao Chen; Jaewon James Lee; Paola A Guerrero; Nicholas Spetsieris; Nikolai Engedal; Sinja Taavitsainen; Kaixian Yu; Julie Livingstone; Vinayak Bhandari; Shawna M Hubert; Najat C Daw; P Andrew Futreal; Eleni Efstathiou; Bora Lim; Andrea Viale; Jianjun Zhang; Matti Nykter; Bogdan A Czerniak; Powel H Brown; Charles Swanton; Pavlos Msaouel; Anirban Maitra; Scott Kopetz; Peter Campbell; Terence P Speed; Paul C Boutros; Hongtu Zhu; Alfonso Urbanucci; Jonas Demeulemeester; Peter Van Loo; Wenyi Wang
Journal:  Nat Biotechnol       Date:  2022-06-13       Impact factor: 54.908

Review 4.  p53 and Tumor Suppression: It Takes a Network.

Authors:  Anthony M Boutelle; Laura D Attardi
Journal:  Trends Cell Biol       Date:  2021-01-28       Impact factor: 20.808

Review 5.  Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy.

Authors:  Tianshu Yang; Yunkai Yang; Yan Wang
Journal:  Clin Epigenetics       Date:  2021-05-17       Impact factor: 6.551

6.  Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Lichun Ma; Limin Wang; Subreen A Khatib; Ching-Wen Chang; Sophia Heinrich; Dana A Dominguez; Marshonna Forgues; Julián Candia; Maria O Hernandez; Michael Kelly; Yongmei Zhao; Bao Tran; Jonathan M Hernandez; Jeremy L Davis; David E Kleiner; Bradford J Wood; Tim F Greten; Xin Wei Wang
Journal:  J Hepatol       Date:  2021-06-30       Impact factor: 25.083

Review 7.  Does Cancer Biology Rely on Parrondo's Principles?

Authors:  Jean-Pascal Capp; Aurora M Nedelcu; Antoine M Dujon; Benjamin Roche; Francesco Catania; Beata Ujvari; Catherine Alix-Panabières; Frédéric Thomas
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

8.  Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation.

Authors:  Julia Rosemann; Lisa Müller; Jonas Weiße; Matthias Kappler; Alexander W Eckert; Markus Glaß; Danny Misiak; Stefan Hüttelmaier; Wolfgang G Ballhausen; Mechthild Hatzfeld; Monika Haemmerle; Tony Gutschner
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

9.  Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.

Authors:  Valentina Melocchi; Elisa Dama; Francesco Mazzarelli; Roberto Cuttano; Tommaso Colangelo; Leonarda Di Candia; Enrico Lugli; Giulia Veronesi; Giuseppe Pelosi; Gian Maria Ferretti; Marco Taurchini; Paolo Graziano; Fabrizio Bianchi
Journal:  Oncogene       Date:  2021-06-25       Impact factor: 9.867

Review 10.  Applications of Single-Cell Omics in Tumor Immunology.

Authors:  Junwei Liu; Saisi Qu; Tongtong Zhang; Yufei Gao; Hongyu Shi; Kaichen Song; Wei Chen; Weiwei Yin
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.